A novel vaccine designed to target one of the most common cancer-driving mutations in patients with pancreatic and colorectal cancer is showing promising results, according to a recently published study.

Roughly half of all cancer deaths worldwide are attributable to modifiable risk factors, according to The Cancer Atlas, a report released by the American Cancer Society and the International Agency for Research on Cancer.

The number of people surviving cancer has improved hugely in the past 50 years, but experts warn progress has been uneven with some cancers with the worst survival rates falling further behind.

A new drug-releasing system, TAR-200, eliminated tumors in 82% of patients in a phase 2 clinical trial for individuals with high-risk non-muscle-invasive bladder cancer whose cancer had previously resisted treatment.

Given the rising incidence of colorectal cancer — particularly among younger adults — and ongoing threats to preventive screening in the U.S., the need for timely, optimized CRC screening is greater than ever.

The 340B Drug Pricing Program was created to improve access to care for low-income and uninsured patients at safety-net hospitals and clinics.

Some cancers are sadly more deadly and more brutal than others – pancreatic cancer being one of them.

A deep learning model using biological age estimations from photographs improved physicians’ survival predictions in patients with incurable cancer receiving palliative care.

Am I the only one who didn't know anyone who had cancer when I was first diagnosed with peritoneal mesothelioma?

A healthy gut microbiome before chemotherapy may help protect patients with breast cancer from heart damage, or cardiotoxicity, caused by cancer treatment, according to data shared in a news release from the European Society of Cardiology.